港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

抗疫概念

1,339.976

-13.088-0.97%

涨家数：3

跌家数：13

平家数：2

市盈率：- -

高：1,360.659

开：1,353.108

低：1,326.242

收：1,353.064

成交量：2.98亿

成交额：35.74亿

市值：8,945.06亿

流通市值：7,507.53亿

数据加载中...

总览新闻资讯

刘强东点赞瑰丽酒店：我和太太在全世界出差，首选瑰丽

九典制药(300705.SZ)拟收购诺纳医药10%股权巩固控股地位

比亚迪整车电子电气架构域控4.0平台通过TÜV南德Automotive SPICE® CL3评估

白云山收购南京医药11.04%股份获批交易额7.49亿元

5家医药上市公司拆分，造富还是另有隐情？

刘强东直播炒菜，“为家人带来幸福是最大的快乐”

礼邦医药冲击港股IPO，专注于肾脏病领域，存在潜在市场重叠风险

山东新华制药股份(00719)获得富马酸伏诺拉生化学原料药上市申请批准通知书

智通财经网

每日卖空追踪 | 同仁堂科技 11月17日卖空量成交5000股，卖空比例为0.78%

每日卖空追踪 | 四环医药 11月17日卖空量成交144.7万股，卖空比例为10.81%

A股收评：指数集体下跌！军工、福建板块强势，贵金属、医药板块走低

业绩不佳但名字“讨彩”？这家公司股价6连板

10月乘用车召回数据出炉：比亚迪领衔，自主品牌占比近九成

ITBEAR科技资讯

比亚迪申请减震器相关专利，减少减震器底部管路数量方便车辆布置

“十五五”规划建议出炉，这些医药细分领域机遇凸显！

比亚迪半导体取得白平衡调整方法及电子设备专利

和誉-B(02256)：和誉医药于CTOS 2025年会展示匹米替尼临床III期 MANEUVER研究长期疗效和安全性数据

医药榜成都医药企业占据两席商业航天榜上榜企业正在成都造火箭

比亚迪中标8900万元大单！

第一商用车网

北京同仁堂集团收购天津同仁堂新进展！百年老字号之争或将落幕

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK1515/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":1339.9764,"timestamp":1763366893506,"preClose":1353.0642,"halted":0,"volume":297705183,"delay":0,"changeRate":-0.009673,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-13.087769,"latestTime":"11-17 16:00:00","open":1353.1075,"high":1360.6588,"low":1326.242,"amount":3573610347,"amplitude":0.025436,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1763429400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1763343000000,1763352000000],[1763355600000,1763366400000]],"pbRate":2.523293,"peRate":27.182624,"turnoverRate":0.003874,"increases":3,"decrements":13,"flats":1,"marketCap":894506306816,"floatMarketCap":750752559872},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":1360.6588,"amplitude":0.025436,"preClose":1353.0642,"low":1326.242,"pbRate":"2.523293","latestPrice":1339.9764,"volume":297705183,"delay":0,"open":1353.1075,"prevYearClose":787.97723,"prevWeekClose":1353.064,"prevMonthClose":1279.786,"prevQuarterClose":1449.838,"fiveDayClose":1276,"twentyDayClose":1324.309,"sixtyDayClose":1371.762,"secType":"PLATE","market":"HK","turnoverRate":0.003874,"peRate":27.182624,"marketCap":894506306816,"floatMarketCap":750752559872,"timestamp":1763366893506,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":3,"down":13,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2584644012","title":"刘强东点赞瑰丽酒店：我和太太在全世界出差，首选瑰丽","url":"https://stock-news.laohu8.com/highlight/detail?id=2584644012","media":"新浪科技","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584644012?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 18:51","pubTimestamp":1763376660,"startTime":"0","endTime":"0","summary":"　　京东品酒会三亚场11月17日在三亚瑰丽酒店举行。京东集团董事局主席刘强东在演讲时点赞瑰丽酒店品牌。　　他说，“过去12年，我和太太在全世界出差，第一优先选择是Rosewood（瑰丽）。我们去到全球任何城市，只要有Rosewood，哪怕多跑20公里，也要选择Rosewood”。　　他给出的理由是：对于我们夫妻二人来讲，Rosewood是最有品味、最有艺术、最有品质的酒店。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/hy/hyjz/2025-11-17/doc-infxtehe3651054.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["HK0000320223.HKD","LU0791590937.USD","BK1249","LU0588545730.USD","BK1619","BK1610","89618","BK4614","BK1583","LU1282651121.HKD","BK1575","IE0008368742.USD","LU0228659784.USD","LU0140636845.USD","LU0315178854.USD","LU1688375341.USD","LU1770034418.SGD","LU0320764755.SGD","LU1366334578.USD","LU0163747925.USD","BK1515","LU1720050803.USD","BK4505","LU0164880469.USD","JD","LU0314109678.HKD","LU0499858602.USD","LU1770036033.HKD","BK4558","LU0348825331.USD","86618","SGXZ62798434.SGD","LU1813983027.USD","LU0588545490.SGD","LU0359201885.HKD","SG9999002562.SGD","LU1188198961.HKD","IE00B29SXG58.USD","LU0828237510.HKD","09618","LU0293314216.USD","LU0052750758.USD","LU0594300419.USD","LU1328277881.USD","BK4526","LU1880383366.USD","BK4585","LU0128522157.USD","06618","LU2242644610.SGD"],"gpt_icon":0},{"id":"2584450641","title":"九典制药(300705.SZ)拟收购诺纳医药10%股权 巩固控股地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2584450641","media":"智通财经","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584450641?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 18:15","pubTimestamp":1763374526,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九典制药(300705.SZ)公告，公司拟使用自有资金4658.45万元，收购上善弘仁持有的诺纳医药10%股权。交易完成后，公司对诺纳医药的持股比例将由60%提升至70%，诺纳医药仍为公司控股子公司。相关事项旨在巩固对诺纳医药控股地位，进一步深化公司在生物医药领域的战略布局。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1370076.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","09939","BK1161","159938","BK1515","300705","BK0239"],"gpt_icon":0},{"id":"2584464113","title":"比亚迪整车电子电气架构域控4.0平台通过TÜV南德Automotive SPICE® CL3评估","url":"https://stock-news.laohu8.com/highlight/detail?id=2584464113","media":"全球TMT","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584464113?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 18:11","pubTimestamp":1763374260,"startTime":"0","endTime":"0","summary":"此次获颁Automotive SPICE CL3级认可，表明比亚迪已在组织层面构建起结构化的过程资产与持续优化机制，为平台化软件开发、跨团队高效协作与产品高质量交付奠定了体系基础。TV南德与比亚迪双方代表合影Automotive SPICE CL3评估的顺利通过，不仅巩固了比亚迪在电子电气架构自主研发领域的领先地位，也体现了TV南德在汽车软件过程改进与评估领域的专业服务能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117181833a6ff23e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117181833a6ff23e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2249611893.SGD","BK1522","BYDDY","LU1770034418.SGD","BK1509","LU1720050803.USD","LU2097828631.EUR","LU0588545730.USD","BK1580","002594","LU0314109678.HKD","LU1868837722.USD","81211","HYDD.SI","LU0315178854.USD","BK1594","00285","LU2399975544.HKD","LU0359201885.HKD","LU0449515922.USD","LU0143863198.USD","SG9999015952.SGD","LU0634319403.HKD","LU1813983027.USD","LU2476274720.SGD","SG9999015945.SGD","BK1610","BK1119","LU0505663152.USD","LU1880383366.USD","01211","LU1251922891.USD","LU0594300419.USD","LU0819123356.HKD","LU0348825331.USD","LU0165289439.USD","LU0823426480.USD","BK1149","SG9999015978.USD","LU0043850808.USD","BK1515","LU0449509016.USD","LU1328277881.USD","LU2097828557.USD","BK1539","LU0052750758.USD","LU0348767384.USD","LU0588545490.SGD","LU0229945570.USD","LU1188198961.HKD"],"gpt_icon":1},{"id":"2584641759","title":"白云山收购南京医药11.04%股份获批 交易额7.49亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584641759","media":"财中社","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584641759?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 18:05","pubTimestamp":1763373927,"startTime":"0","endTime":"0","summary":"11月17日，白云山（600332/00874）发布公告，广州广药二期基金股权投资合伙企业（有限合伙）已收到国资主管单位广州医药集团有限公司的批复，同意以协议转让方式收购南京医药股份有限公司（600713）1.45亿股非限售股份（占南京医药股份总数11.04%）的股份，转让价款为7.49亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511173566393681.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1606","BK1515","BK1191","00874","BK1521","BK1197"],"gpt_icon":0},{"id":"2584642899","title":"5家医药上市公司拆分，造富还是另有隐情？","url":"https://stock-news.laohu8.com/highlight/detail?id=2584642899","media":"投资者网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584642899?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 18:01","pubTimestamp":1763373702,"startTime":"0","endTime":"0","summary":"《投资者网》蔡俊医药板块上市公司，又掀拆分上市浪潮。截至目前，拆分潮涉及的上市公司有四环医药、同仁堂、复星医药、康哲药业、东诚药业。2024年，轩竹生物主动撤回上市申请，并转向港交所递表。今年9月，同仁堂医养通过港交所聆讯，成为同仁堂系第四家上市公司。该子公司主营人用疫苗，现有四款疫苗获批上市。今年8月，东诚药业公告拆分蓝纳成赴港上市。对母公司而言，拆分有两层意义。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117181802a4a76caa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117181802a4a76caa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1574","09939","BK1161","BK1191","BK1593","00460","BK1600"],"gpt_icon":0},{"id":"2584292649","title":"刘强东直播炒菜，“为家人带来幸福是最大的快乐”","url":"https://stock-news.laohu8.com/highlight/detail?id=2584292649","media":"睿见Economy","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584292649?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 17:52","pubTimestamp":1763373120,"startTime":"0","endTime":"0","summary":"　　11月17日下午消息，在今日的京东品酒会上，京东集团创始人刘强东直播炒菜。刘强东表示，做菜也是他的一个爱好，可能很多人不一定喜欢做菜，但对他来讲做菜是一个非常好的解压方式，可以沉浸在整个过程，可以好几十分钟不用说话，可以专注于思考。“另外厨师永远是为家人带来快乐，如果能做出好吃的菜，为家人带来幸福，也是我们最大的快乐”他说。　　此次刘强东现场炒了卷饼尖椒小鱼和酱豆炒蛋两道宿迁菜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/meeting/2025-11-17/doc-infxtehe3630852.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SG9999002562.SGD","LU1282649810.SGD","LU1813983027.USD","LU0791591158.USD","89618","LU1794554557.SGD","BK4503","LU1188198961.HKD","LU0140636845.USD","LU0327786744.USD","LU0345776255.USD","06618","LU2039709279.SGD","BK4526","LU0865486749.SGD","LU0348805143.USD","LU0588546209.SGD","LU0543330483.HKD","LU0348825331.USD","LU0588545904.SGD","LU1366334578.USD","LU0791590937.USD","86618","LU1720050803.USD","LU0828237510.HKD","BK4614","LU1023057109.AUD","LU1719994722.HKD","LU0293314216.USD","BK1610","LU0039217434.USD","BK1142","BK1515","SG9999002828.SGD","BK1588","BK1249","LU0315179316.USD","JD","LU0051755006.USD","LU0315178854.USD","LU0359202008.SGD","LU0572944931.SGD","LU0228659784.USD","09618","LU0469268626.HKD","LU0431992006.USD","IE0032431581.USD","LU0326950275.SGD","LU0463099449.HKD","SG9999001226.SGD"],"gpt_icon":0},{"id":"2584864699","title":"礼邦医药冲击港股IPO，专注于肾脏病领域，存在潜在市场重叠风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2584864699","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584864699?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 17:30","pubTimestamp":1763371806,"startTime":"0","endTime":"0","summary":"两年半累计亏损9.1亿元","market":"us","thumbnail":"https://img2.gelonghui.com/16c8d-f2669b06-8436-4774-bfc1-8e7cafddcf5f.jpg?guru_height=891&guru_width=1364&guru_size=109981","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/16c8d-f2669b06-8436-4774-bfc1-8e7cafddcf5f.jpg?guru_height=891&guru_width=1364&guru_size=109981"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/3211874","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1161","09939","BK1574","BK1515"],"gpt_icon":0},{"id":"2584643171","title":"山东新华制药股份(00719)获得富马酸伏诺拉生化学原料药上市申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2584643171","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584643171?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 16:49","pubTimestamp":1763369355,"startTime":"0","endTime":"0","summary":"山东新华制药股份(00719)发布公告，近日，山东新华制药股份有限公司(“新华制药...","market":"sg","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_39.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_39.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369985.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"山东新华制药股份(00719)获得富马酸伏诺拉生化学原料药上市申请批准通知书","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["00719","BK1191","BK1515"],"gpt_icon":0},{"id":"2584644705","title":"每日卖空追踪 | 同仁堂科技 11月17日卖空量成交5000股，卖空比例为0.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584644705","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584644705?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 16:30","pubTimestamp":1763368221,"startTime":"0","endTime":"0","summary":"同仁堂科技北京时间11月17日，跌0.41%，卖空量成交5000股，较上一交易日减少44.44%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117163316976e73ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117163316976e73ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1606","01666","BK1515","BK1583"],"gpt_icon":0},{"id":"2584642884","title":"每日卖空追踪 | 四环医药 11月17日卖空量成交144.7万股，卖空比例为10.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584642884","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584642884?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 16:30","pubTimestamp":1763368211,"startTime":"0","endTime":"0","summary":"四环医药北京时间11月17日，跌0.7%，卖空量成交144.7万股，较上一交易日减少45.76%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117163104a6fee41d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117163104a6fee41d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1600","BK1593","BK1191","BK1515","00460"],"gpt_icon":0},{"id":"2584338610","title":"A股收评：指数集体下跌！军工、福建板块强势，贵金属、医药板块走低","url":"https://stock-news.laohu8.com/highlight/detail?id=2584338610","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584338610?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 15:40","pubTimestamp":1763365233,"startTime":"0","endTime":"0","summary":"沪深两市成交额1.91万亿","market":"fut","thumbnail":"https://img3.gelonghui.com/a48cd-6da2875c-c1af-4256-a34f-0987cf96fa90.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/a48cd-6da2875c-c1af-4256-a34f-0987cf96fa90.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/3211089","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["LU0072913022.USD","BK1161","BK0188","BK0278","LU1226287529.USD","LU0067412154.USD","LU1807302812.USD","BK1515","BK0187","BK0183","LU0880133367.SGD","09939","BK1574","LU1655091616.SGD","BK0028","BK0012","LU1781817850.SGD","000001","IE00B0JY6N72.USD","LU1580142542.USD","LU1993786604.SGD","LU0501845795.SGD","BK0201"],"gpt_icon":0},{"id":"2584761624","title":"业绩不佳但名字“讨彩”？这家公司股价6连板","url":"https://stock-news.laohu8.com/highlight/detail?id=2584761624","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584761624?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 12:53","pubTimestamp":1763355180,"startTime":"0","endTime":"0","summary":"　　在医药板块整体表现平平的背景下，哈药集团人民同泰医药股份有限公司股价却持续飙升。　　Wind数据显示，截至11月17日午间收盘，人民同泰已连续6个交易日涨停，公司股价从11月10日的9.20元/股一路飙升至11月17日的16.64元/股，累计涨幅高达77.21%，总市值达到96亿元。2025年前三季度，人民同泰实现营业收入78.46亿元，同比增长2.19%；归属于上市公司股东的净利润1.12亿元，同比下降45.69%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2025-11-17/doc-infxstsk3761786.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","600829","09939","BK1161","BK1574","BK0250"],"gpt_icon":0},{"id":"2584198615","title":"10月乘用车召回数据出炉：比亚迪领衔，自主品牌占比近九成","url":"https://stock-news.laohu8.com/highlight/detail?id=2584198615","media":"ITBEAR科技资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584198615?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 11:12","pubTimestamp":1763349169,"startTime":"0","endTime":"0","summary":"此次召回行动中，自主品牌占据主导地位，比亚迪、吉利与理想三大品牌合计召回数量超过17万辆，占当月召回总量的近九成。具体数据显示，自主品牌召回规模显著高于其他车系。此次召回行动中，新能源车专用装置问题成为关注焦点。数据显示，比亚迪召回的11.58万辆车辆中，绝大部分为新能源汽车，这反映出新能源车型在规模化生产过程中面临的品质管控挑战。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117114327a6fe59fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117114327a6fe59fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["81211","LU0708995583.HKD","LU0244354667.USD","LU1720050803.USD","LU0469268626.HKD","LU0164872284.USD","LU2348774022.SGD","LU2476274308.USD","SG9999015978.USD","LU2153592121.USD","LU0823414478.USD","BK1515","LU0348827113.USD","LU0823426480.USD","LU2097828714.EUR","02015","LU0348825331.USD","LU0561508036.HKD","LU0214875030.USD","LU2476274720.SGD","LU0348735423.USD","01211","LU0052750758.USD","LU1868838027.USD","SG9999015986.USD","LU0327786744.USD","LU1880383366.USD","BK1522","002594","LU1961090484.USD","LU1868837565.USD","LU0819121731.USD","LU0043850808.USD","LU0650527681.SGD","LU1868837722.USD","LU0856984785.SGD","SG9999006514.SGD","BYDDY","LU0175139822.USD","LU0516422366.SGD","LU2449936058.SGD","LU0871576103.HKD","LU0417516738.SGD","SG9999002463.SGD","LU2294711713.HKD","LU0348767384.USD","HYDD.SI","00285","LU0039217434.USD","LU1880383440.USD"],"gpt_icon":1},{"id":"2584734690","title":"比亚迪申请减震器相关专利，减少减震器底部管路数量方便车辆布置","url":"https://stock-news.laohu8.com/highlight/detail?id=2584734690","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584734690?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 09:51","pubTimestamp":1763344286,"startTime":"0","endTime":"0","summary":"国家知识产权局信息显示，比亚迪股份有限公司申请一项名为“减震器、悬挂系统和车辆”的专利，公开号 CN 120946730 A，申请日期为 2025 年 07 月。通过在活塞杆上设置于第二工作腔连通的内部通道，使得可以直接通过内部通道直接抽取第二工作腔内的液体或者向第二工作腔内注入液体，即可以把内部通道直接作为一条液体回路使用，从而减少了减震器底部管路的数量，方便减震器在车辆上的布置。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117100311a4a66b2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117100311a4a66b2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0417516902.SGD","LU2449936058.SGD","00285","BK1504","BK1582","LU2506951792.HKD","LU0531971595.HKD","LU1880383440.USD","LU1328277881.USD","LU0348825331.USD","LU0449515922.USD","LU0516423174.USD","01211","SG9999002463.SGD","LU0463099449.HKD","LU2097828474.EUR","LU0594300179.USD","BK1522","HYDD.SI","LU0865486749.SGD","LU1023057109.AUD","LU0588545904.SGD","LU0417516738.SGD","LU2097828714.EUR","LU0289960550.SGD","LU0823038988.USD","LU0572944931.SGD","LU2778985437.USD","LU0054450605.USD","002594","LU0828238088.HKD","LU0039217434.USD","LU0307460666.USD","LU0269904917.USD","LU0359201885.HKD","BK1580","BYDDY","BK1515","LU0605514214.HKD","LU1880383366.USD","SG9999015978.USD","LU2357125470.USD","SG9999001226.SGD","LU1861214812.USD","81211","LU0326950275.SGD","BK1509","LU0084288322.USD","LU0531970944.HKD","LU1242518857.USD"],"gpt_icon":1},{"id":"2584764358","title":"“十五五”规划建议出炉，这些医药细分领域机遇凸显！","url":"https://stock-news.laohu8.com/highlight/detail?id=2584764358","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584764358?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 09:35","pubTimestamp":1763343311,"startTime":"0","endTime":"0","summary":"随着“十五五”规划建议出炉，为中国医药行业锚定了“创新驱动、自主可控、普惠可及”的发展航向。创新药作为医药产业的核心引擎，在“十五五”规划“支持创新药发展”的政策导向下迎来黄金发展期。“十五五”规划明确支持医疗器械发展，医疗设备“以旧换新”政策与医疗卫生强基工程的推进，直接拉动基层医疗设备更新需求，AI影像、心血管介入器械等细分领域国产化率已突破50%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511170936269508c76b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511170936269508c76b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1588","LU1770034418.SGD","BK1500","LU0588546209.SGD","LU1303224171.USD","LU0307460666.USD","LU1719994722.HKD","BK1574","BK1583","BK1515","06160","09939","LU1969619763.USD","LU1251922891.USD","LU2328871848.SGD","BK1161"],"gpt_icon":0},{"id":"2584692331","title":"比亚迪半导体取得白平衡调整方法及电子设备专利","url":"https://stock-news.laohu8.com/highlight/detail?id=2584692331","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584692331?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 08:31","pubTimestamp":1763339486,"startTime":"0","endTime":"0","summary":"国家知识产权局信息显示，比亚迪半导体股份有限公司取得一项名为“白平衡调整方法及电子设备”的专利，授权公告号CN 115604450 B，申请日期为2021年06月。天眼查资料显示，比亚迪半导体股份有限公司，成立于2004年，位于深圳市，是一家以从事研究和试验发展为主的企业。通过天眼查大数据分析，比亚迪半导体股份有限公司共对外投资了9家企业，参与招投标项目511次，财产线索方面有商标信息3条，专利信息1469条，此外企业还拥有行政许可109个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511170844089508b13a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511170844089508b13a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1720050803.USD","LU0175139822.USD","LU2097828474.EUR","LU1861214812.USD","LU0561508036.HKD","LU0856984785.SGD","HYDD.SI","LU2097828631.EUR","LU0259732245.USD","SG9999006514.SGD","LU0143863198.USD","LU2348774022.SGD","SG9999015978.USD","LU0823414551.USD","81211","BK1515","LU0505663152.USD","LU2097828805.USD","BYDDY","LU0359201612.USD","LU0588545490.SGD","LU0516422952.EUR","01211","LU0348825331.USD","00285","LU0052750758.USD","LU1794554557.SGD","LU1861219969.SGD","SG9999006597.SGD","LU2153592121.USD","LU1242518931.SGD","LU2097828557.USD","SG9999015945.SGD","LU2476274308.USD","LU0289739343.SGD","LU1813983027.USD","LU0823426308.USD","SG9999015952.SGD","LU1770034418.SGD","LU0819123356.HKD","BK1607","002594","LU0593848301.USD","LU0511384066.AUD","LU0348827113.USD","LU0274383008.USD","LU0214875030.USD","LU0359202008.SGD","LU0211977185.USD","LU0043850808.USD"],"gpt_icon":0},{"id":"2584691270","title":"和誉-B(02256)：和誉医药于CTOS 2025年会展示匹米替尼临床III期 MANEUVER研究长期疗效和安全性数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2584691270","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584691270?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 08:02","pubTimestamp":1763337752,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)发布公告，本公司的附属公司上海和誉生物医药科技有限公司(和誉医药)宣布，其在结缔组织肿瘤学会(CTOS)2025年会上以壁报形式展示了匹米替尼(pimicotinib/ABSK021)治疗腱鞘巨细胞瘤(TGCT)患者的全球III期MANEUVER研究的长期疗效、安全性及患者报告结果数据。该长期分析显示，持续接受匹米替尼治疗可为TGCT患者在肿瘤缓解方面带来疗效持续提升与患者报告结果(包括疼痛与功能)的进一步改善，同时维持可接受的安全性，强化了匹米替尼在适合患者中的长期应用潜力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369759.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4134","LU2476274308.USD","III","BK1515","02256","LU2476274720.SGD","CTOS","BK1161","IE00B543WZ88.USD","IE00BPRC5H50.USD","LU2778985437.USD","BK1574","LU2488822045.USD","BK4104","IE00B5MMRT66.SGD","159938","09939"],"gpt_icon":0},{"id":"2584974106","title":"医药榜成都医药企业占据两席 商业航天榜上榜企业正在成都造火箭","url":"https://stock-news.laohu8.com/highlight/detail?id=2584974106","media":"成都日报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584974106?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 03:14","pubTimestamp":1763320440,"startTime":"0","endTime":"0","summary":"转自：成都日报锦观福布斯中国创新力企业50强榜出炉医药榜成都医药企业占据两席 商业航天榜上榜企业正在成都造火箭星际荣耀可重复使用液体运载火箭生产总部基地效果图。榜单显示，成都生物医药行业表现不俗，在入选的全国8家医药企业中，成都占据两席，分别是百利天恒和科伦博泰生物。值得关注的还有，在商业航天领域创新力企业榜中，星际荣耀上榜，为商业航天领域两家上榜企业之一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111703162295084ef3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111703162295084ef3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1515","BK1161","02615","LU0196878994.USD","06990","09939"],"gpt_icon":0},{"id":"2583662629","title":"比亚迪中标8900万元大单！","url":"https://stock-news.laohu8.com/highlight/detail?id=2583662629","media":"第一商用车网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583662629?lang=zh_cn&edition=fundamental","pubTime":"2025-11-16 21:13","pubTimestamp":1763298794,"startTime":"0","endTime":"0","summary":"近日，济南公共交通集团有限公司纯电动公交车采购项目中标候选人公示发布。公告显示，中标单位为济南比亚迪汽车有限公司，中标金额为8900万元。● 潍柴65万 玉柴增27%领涨 全柴/东康份额上升 前10月多缸柴油机销量来了 | 头条● 大电量新能源轻卡车型大比拼！谁会成为2025年度“黑马”？● 10月微卡销量再破3万辆！黑马杀进前七 奇瑞/长安和TA稳拿三甲●64辆新能源公交车招标？● 2030年目标6.5万辆 联合重卡在奇瑞的赋能下将怎么干？| 头条","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251116212012a6fd31e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251116212012a6fd31e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2449936058.SGD","BK1515","LU0856984785.SGD","LU1720050803.USD","LU0359202008.SGD","LU0594300419.USD","LU0269904917.USD","LU0572944931.SGD","LU1251922891.USD","LU1770034418.SGD","LU0320764599.SGD","002594","LU0469268626.HKD","LU0084288322.USD","LU0229945570.USD","SG9999014674.SGD","LU1868837565.USD","LU0417516738.SGD","81211","LU0979878070.USD","IE00BD6J9T35.USD","LU0043850808.USD","LU0417516902.SGD","LU1861214812.USD","LU0289739343.SGD","LU0449515922.USD","01211","SG9999015945.SGD","SG9999015986.USD","00285","LU0307460666.USD","BYDDY","SG9999015978.USD","LU0348767384.USD","LU0588545490.SGD","SG9999006597.SGD","LU0348827113.USD","HYDD.SI","LU1023057109.AUD","LU1868838027.USD","LU2360107325.USD","LU0164872284.USD","LU0588545730.USD","LU0516423091.SGD","LU2476274308.USD","LU0823414478.USD","LU0511384066.AUD","LU0708995583.HKD","LU0259732245.USD","BK1119"],"gpt_icon":0},{"id":"2583662780","title":"北京同仁堂集团收购天津同仁堂新进展！百年老字号之争或将落幕","url":"https://stock-news.laohu8.com/highlight/detail?id=2583662780","media":"红星新闻","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583662780?lang=zh_cn&edition=fundamental","pubTime":"2025-11-16 20:43","pubTimestamp":1763296980,"startTime":"0","endTime":"0","summary":"根据经营者集中简易案件公示表，交易完成后，北京同仁堂集团将持有天津同仁堂60%的股份，单独控制天津同仁堂。在此次被北京同仁堂集团收购前，天津同仁堂与北京同仁堂集团并无股权上的关联，但二者历史渊源颇深，且在品牌、商标字号等方面纷争不断，甚至一度对簿公堂。据市场监管总局经营者集中反垄断业务系统网站，11月5日，北京同仁堂集团收购天津同仁堂股权案进入受理阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251116204336976cd086&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251116204336976cd086&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1515","03613","01666","BK1606","BK1191"],"gpt_icon":0}],"pageSize":20,"totalPage":22,"pageCount":1,"totalSize":440,"code":"91000000","status":"200"}]}}